Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.67 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 737.5% year-over-year to $0.67; the TTM value through Dec 2025 reached $2.26, up 370.83%, while the annual FY2025 figure was $1.19, 1883.33% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.67 in Q4 2025 per PAHC's latest filing, up from $0.65 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.67 in Q4 2025 and bottomed at -$0.2 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.27, with a median of $0.23 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 300.0% in 2023, then surged 2050.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.43 in 2021, then tumbled by 58.14% to $0.18 in 2022, then crashed by 83.33% to $0.03 in 2023, then soared by 166.67% to $0.08 in 2024, then skyrocketed by 737.5% to $0.67 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.67 in Q4 2025, $0.65 in Q3 2025, and $0.43 in Q2 2025.